Canada Digital Biomarkers Market Size & Outlook, 2023-2030
Related Markets
Canada digital biomarkers market highlights
- The Canada digital biomarkers market generated a revenue of USD 640.7 million in 2023 and is expected to reach USD 2,751.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 23.1% from 2024 to 2030.
- In terms of segment, wearable was the largest revenue generating type in 2023.
- Mobile based Applications is the most lucrative type segment registering the fastest growth during the forecast period.
Digital biomarkers market data book summary
| Market revenue in 2023 | USD 640.7 million |
| Market revenue in 2030 | USD 2,751.7 million |
| Growth rate | 23.1% (CAGR from 2023 to 2030) |
| Largest segment | Wearable |
| Fastest growing segment | Mobile based Applications |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wearable, Mobile based Applications, Sensors |
| Key market players worldwide | Amgen Inc, Biogen Inc, Pfizer Inc, ActiGraph, AliveCor, Koneksa Health, Altoida, Empatica, VivoSense, Ixico, Neurotrack, Aural Analytics, Sonde Health, Clario, Imagene AI, Brainomix, Kinsa, Feel Therapeutics |
Other key industry trends
- In terms of revenue, Canada accounted for 18.7% of the global digital biomarkers market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. digital biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,751.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Biomarkers Market Scope
Digital Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Feel Therapeutics | View profile | 11-50 | San Francisco, California, United States, North America | https://www.feeltherapeutics.com/ |
| Kinsa | View profile | 11-50 | San Francisco, California, United States, North America | http://www.kinsahealth.com |
| Brainomix | View profile | 11-50 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.brainomix.com |
| Imagene AI | View profile | 11-50 | Tel Aviv, Tel Aviv, Israel, Asia | https://imagene-ai.com |
| Clario | View profile | 5001-10000 | Philadelphia, Pennsylvania, United States, North America | https://clario.com/ |
| Sonde Health | View profile | 1-10 | Boston, Massachusetts, United States, North America | https://www.sondehealth.com |
| Aural Analytics | View profile | 11-50 | Scottsdale, Arizona, United States, North America | https://auralanalytics.com/ |
| Neurotrack | View profile | 11-50 | Redwood City, California, United States, North America | https://neurotrack.com/ |
| Ixico | View profile | 51-100 | London, England, United Kingdom, Europe | http://www.ixico.com |
| VivoSense | View profile | 11-50 | Newport Coast, California, United States, North America | https://www.vivosense.com/ |
| Empatica | View profile | 51-100 | Cambridge, Massachusetts, United States, North America | https://www.empatica.com |
| Altoida | View profile | 11-50 | Washington, District of Columbia, United States, North America | http://www.altoida.com |
| Koneksa Health | View profile | 101-250 | New York, New York, United States, North America | http://www.koneksahealth.com |
| AliveCor | View profile | 101-250 | Mountain View, California, United States, North America | https://alivecor.com |
| ActiGraph | View profile | 11-50 | Pensacola, Florida, United States, North America | http://www.actigraphcorp.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
Canada digital biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital biomarkers market will help companies and investors design strategic landscapes.
Wearable was the largest segment with a revenue share of 40.46% in 2023. Horizon Databook has segmented the Canada digital biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada digital biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada digital biomarkers market databook
-
Our clientele includes a mix of digital biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada digital biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Canada digital biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada digital biomarkers market size, by clinical practice, 2018-2030 (US$M)
Canada Digital Biomarkers Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
